Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study

D. J. Lange, K. J. Felice, B. W. Festoff, M. J. Gawel, D. F. Gelinas, R. Kratz, E. C. Lai, M. F. Murphy, H. M. Natter, F. H. Norris, S. Rudnicki

Research output: Contribution to journalArticle

49 Scopus citations
Original languageEnglish (US)
Pages (from-to)S93-S95
Issue number4 SUPPL.
StatePublished - Oct 1996

ASJC Scopus subject areas

  • Clinical Neurology

Cite this